Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Buijs, W.C.A.M."'
Autor:
Nieuwlaat, W.A., Hermus, A.R.M.M., Ross, H.A., Buijs, W.C.A.M., Edelbroek, M., Bus, J.W., Corstens, F.H.M., Huysmans, D.A.K.C.
Publikováno v:
The Journal of Nuclear Medicine (1978), 45, 4, pp. 626-33
The Journal of Nuclear Medicine (1978), 45, 626-33
The Journal of Nuclear Medicine (1978), 45, 626-33
Contains fulltext : 57827.pdf (Publisher’s version ) (Closed access) A single, low dose of recombinant human thyroid-stimulating hormone (rhTSH) doubles 24-h RAIU and causes a more homogeneous distribution of radioiodine on thyroid scintigrams of p
Autor:
Brouwers, A.H., Buijs, W.C.A.M., Oosterwijk, E., Boerman, O.C., Mala, C., Mulder, P.H.M. de, Corstens, F.H.M., Mulders, P.F.A., Oyen, W.J.G.
Publikováno v:
Clinical Cancer Research, 9, 3953S-60S
Clinical Cancer Research, 9, 10 Pt 2, pp. 3953S-60S
Clinical Cancer Research, 9, 10 Pt 2, pp. 3953S-60S
Item does not contain fulltext PURPOSE: There is increasing evidence that the chimeric monoclonal antibody G250 (cG250) can be internalized by G250 antigen-expressing renal cell carcinoma (RCC) cells. Thus, accumulation in tumors of cG250 labeled wit
Autor:
Kemerink, G.J., Liem, I.H., Hofstra, L., Boersma, H., Buijs, W.C.A.M., Reutelingsperger, C.P.M., Heidendal, G.A.K.
Publikováno v:
The Journal of Nuclear Medicine (1978), 42, pp. 382-387
The Journal of Nuclear Medicine (1978), 42, 382-387
The Journal of Nuclear Medicine (1978), 42, 382-387
Item does not contain fulltext
Autor:
Brouwers, A.H., Mulders, P.F.A., Oosterwijk, E., Buijs, W.C.A.M., Corstens, F.H.M., Boerman, O.C., Oyen, W.J.G.
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals, 19, 4, pp. 466-77
Cancer Biotherapy & Radiopharmaceuticals, 19, 466-77
Cancer Biotherapy & Radiopharmaceuticals, 19, 466-77
Contains fulltext : 59348.pdf (Publisher’s version ) (Open Access) INTRODUCTION: Clinical and animal studies of chimeric monoclonal antibody G250 (moAb cG250) for the targeting of clear-cell renal cell carcinoma (RCC), to date, have been with the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::db18ca0338a0ce00203a8b0c73bbcd4b
https://hdl.handle.net/2066/59348
https://hdl.handle.net/2066/59348
Autor:
Postema, E.J., Borjesson, P.K., Buijs, W.C.A.M., Roos, J.C., Marres, H.A.M., Boerman, O.C., Bree, R. de, Lang, M., Munzert, G., Dongen, G.A.M.S. van, Oyen, W.J.G.
Publikováno v:
The Journal of Nuclear Medicine (1978), 44, 1690-9
The Journal of Nuclear Medicine (1978), 44, 10, pp. 1690-9
The Journal of Nuclear Medicine (1978), 44, 10, pp. 1690-9
Item does not contain fulltext From December 1999 until July 2001, a phase I dose escalation study was performed with (186)Re-labeled bivatuzumab, a humanized monoclonal antibody against CD44v6, on patients with inoperable recurrent or metastatic hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::918a0414b7f3284a7744b908e6aff933
http://hdl.handle.net/2066/142623
http://hdl.handle.net/2066/142623
Publikováno v:
The Journal of Nuclear Medicine (1978), 44, 1707-8
The Journal of Nuclear Medicine (1978), 44, 10, pp. 1707-8
The Journal of Nuclear Medicine (1978), 44, 10, pp. 1707-8
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c17cc1470008820e5204c80d6cd13c43
http://hdl.handle.net/2066/272877
http://hdl.handle.net/2066/272877
Autor:
Dams, E.Th.M., Oyen, W.J.G., Boerman, O.C., Storm, G., Laverman, P., Kok, P.J.M., Buijs, W.C.A.M., Bakker, H., Meer, J.W.M. van der, Corstens, F.H.M.
Publikováno v:
The Journal of Nuclear Medicine (1978), 41, 622-30
The Journal of Nuclear Medicine (1978), 41, pp. 622-30
The Journal of Nuclear Medicine (1978), 41, pp. 622-30
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e246fd2e6e0b2365c5d6303e8c16ddfc
http://hdl.handle.net/2066/120615
http://hdl.handle.net/2066/120615
Autor:
Dams, E.T.M., Oyen, W.J.G., Boerman, O.C., Storm, G., Laverman, P., Kok, P.J.M., Buijs, W.C.A.M., Bakker, H., Meer, J.W.M. van der, Corstens, F.H.M.
Publikováno v:
The Journal of Nuclear Medicine (1978), 41, 4, pp. 622-630
The Journal of Nuclear Medicine (1978), 41, 622-630. Soc nuclear medicine inc
The Journal of Nuclear Medicine (1978), 41, 622-630. Soc nuclear medicine inc
Contains fulltext : 19827.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5e10117f508fe8777e3fedcbf6fe197b
https://hdl.handle.net/2066/19827
https://hdl.handle.net/2066/19827
Autor:
Steffens, M.G., Boerman, O.C., Mulder, P.H.M. de, Oyen, W.J.G., Buijs, W.C.A.M., Witjes, J.A., Broek, W.J.A.A. van den, Oosterwijk-Wakka, J.C., Debruyne, F.M.J., Corstens, F.H.M., Oosterwijk, E.
Publikováno v:
Clinical Cancer Research, 5, 10 Suppl, pp. 3268s-3274s
Clinical Cancer Research, 5, 3268s-3274s
Clinical Cancer Research, 5, 3268s-3274s
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::31ddf9d860523a67e32bb0f75080f94a
https://hdl.handle.net/2066/123757
https://hdl.handle.net/2066/123757
Autor:
Buijs, W.C.A.M., Oyen, W.J.G., Dams, E.T.M., Boerman, O.C., Siegel, J.A., Claessens, R.A.M.J., Meer, J.W.M. van der, Corstens, F.H.M.
Publikováno v:
Nuclear Medicine Communications, 19, 743-751. Lippincott williams & wilkins
Nuclear Medicine Communications, 19, 8, pp. 743-751
Nuclear Medicine Communications, 19, 8, pp. 743-751
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5ab5f48646c6f208702945ff6a33c384
http://hdl.handle.net/2066/19759
http://hdl.handle.net/2066/19759